References
- Herrada, J.; Cabanillas, F.; Rice, L.; , et al. The clinical behavior of localized and multicentric Castleman disease. Ann. Int. Med. 1998, 128, 657–662. [PUBMED], [INFOTRIEVE], [CSA]
- Corbellino, M.; Bestetti, G.; Scalamogna, C.; , et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 2001, 98 (12), 3473–3475. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Makoto, I.; Eiichi, O.; Kanji, K.; , et al. Successful treatment of multicentric castleman's disease with bilateral orbital tumour using rituximab. Br. J. Haematol. 2003, 121 (5), 818. [CROSSREF], [CSA]
- Marcelin, A G.; Aaron, L.; Mateus, C.; , et al Rituximab therapy for HIV-associated Castleman disease. Blood 2003, 102 (8), 2786–2788. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marrache, F.; Larroche, C.; Memain, N.; , et al. Prolonged remission of HIV-associated multicentric Castleman's disease with an anti-CD20 monoclonal antibody as primary therapy. AIDS 2003, 17 (9), 1409–1410. [PUBMED], [INFOTRIEVE], [CROSSREF]